Alamar Biosciences, Inc.
ALMR · XNASCIK 2104204fmd_11JYAMFPN7Q63YN7HEAFW8VXAWManufacturing · Laboratory Analytical InstrumentsTemplate: Standard
Coverage: Jan 01, 2025 to Sep 30, 2026, 6 periods
Latest quarter · Q3 FY2026
Millions- Total revenues
- 34
- Gross profit
- 21
- Operating income
- (15)
- Net income
- (13)
- Free cash flow
- (15)
Daily close · ALMRIEX trades only
Nov 09, 2026 to Nov 11, 2026 · 3 sessions31.68 USD
Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms